CLINICAL_TRIALS
trial_result
· 2018-03-20
Clinical Trial Update: Evaluation of ATx201 as a Topical Antibiotic Agent [Phase 1, Phase 2]
Summary
The document reports completion of a Phase 1/2 study evaluating ATx201 as a topical antibiotic for bacterial infections.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNION therapeutics | Conditions: Infection, Bacterial | Phase 1, Phase 2 | Status: COMPLETED